PL.23 Use of Quantitative Fetal Fibronectin May Improve Risk Assessment in Symptomatic Women at Risk of Preterm Birth

Abstract

Background The presence of raised fetal fibronectin (fFN) levels in cervicovaginal secretions between 24–34 weeks gestation is associated with an increased risk of spontaneous preterm birth in symptomatic women. Recent...